PATENT CLAIM ANALYSIS

Application Number: 15755390
Application Type: Utility
Filing Date: 2018-02
Publication Date: 2018-09
Patent Classification: ["514", "217010"]

Abstract:
The present invention provides novel means and methods for treatment auf immunemediated inflammatory diseases.

Claim (Index 11):
Compounds for the use of any one of the preceding claims, wherein treatment results in levels of\n (i) surface CD40: and/or (ii) surface CD86; and/or (iii) surface MHCII and/or (iv) surface CD80 on immune cells.

Metadata:
- Claim Count in Document: 1.0
- Percentile: 88.0
- Lexical Diversity: 1.0
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['11901843', '09886773', '12786221', '11801473', '13567146']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7696347625731588
- 35 USC 102 Novelty (BERT): 0.5064217441494204
- Combined Prediction Score: 0.743313460730785
- Mean Citation Score: 226.707182
- Max Citation Score: 232.65176
- Similarity Product: 147.33709918613434

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test